Publication dates

All regions

Vaccine Industry, September 2014 Market Reports from Top Publishers

You might be interested in: diagnostic, disease testing, microbiology, more »


 
1-20 of about 2 900 reports for Vaccine

Taiwan Pharmaceuticals and Healthcare Report Q4 2014

Taiwan Pharmaceuticals and Healthcare Report Q4 2014

  • $ 1 300
  • Industry report
  • September 2014
  • by Business Monitor International

Includes 3 FREE quarterly updates BMI View: While Taiwan's intellectual property regime has some deficiencies, drug pricing remains the key issue of concern for the Pharmaceutical Research and Manufacturers ...

Adacel Technologies Ltd

Adacel Technologies Ltd

  • $ 55
  • Company report
  • September 2014
  • by Wright Investors' Service

A textual analysis of the financial results for Adacel Technologies Ltd compared to selected competitors. Also included are quantitative analyses of the company's financial statements, extensive ratio ...

Global Pneumococcal Vaccines Market 2014-2018

Global Pneumococcal Vaccines Market 2014-2018

  • $ 2 500
  • Industry report
  • September 2014
  • by Infiniti Research Limited

... vaccination involves the introduction of dead or weakened antigen into the human body, which in turn produces lymphocytes to counter the infection and any future invasions by that antigen ...

VBI Vaccines Incorporation

VBI Vaccines Incorporation

  • $ 55
  • Company report
  • September 2014
  • by Wright Investors' Service

... Vbi vaccines incorporation a textual analysis of the financial results for vbi vaccines incorporation compared to selected competitors. Also included are quantitative analyses of the company ...

Global Animal Vaccines Market 2014-2018

Global Animal Vaccines Market 2014-2018

  • $ 3 000
  • Industry report
  • September 2014
  • by Infiniti Research Limited

... Weakened or dead microbes that can cause a particular disease when in their healthy state. Some of the animal vaccines are also formulated using a part of a microbe's body such as protein subunits or toxic ...

Global Hepatitis B Vaccines Market 2014-2018

Global Hepatitis B Vaccines Market 2014-2018

  • $ 2 500
  • Industry report
  • September 2014
  • by Infiniti Research Limited

... Global hepatitis b vaccines market 2014-2018 about hepatitis b vaccineshepatitis b is an inflammatory condition that occurs due to infection by hepatitis b virus. Hepatitis b virus ...

Pipeline Analysis of Hospital Acquired Pneumonia Drugs Market (Tedizolid Phosphate, Ceftolozane/Tazobactam, Ceftazidime/Avibactam, Amikacin Inhale, Plazomicin, and Synflorix) - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2014 - 202

Pipeline Analysis of Hospital Acquired Pneumonia Drugs Market (Tedizolid Phosphate, Ceftolozane/Tazobactam, Ceftazidime/Avibactam, Amikacin Inhale, Plazomicin, and Synflorix) - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2014 - 202

  • $ 4 795
  • Industry report
  • September 2014
  • by Transparency Market Research

... Market analysis of major drugs and vaccines for hospital acquired pneumonia 3.6.1 Revenue trend of major branded drugs and vaccines in nosocomial pneumonia market (usd million)chapter 4 ...

Cancer Immunotherapy: immune checkpoint inhibitors, cancer vaccines, and adoptive T-cell therapies

Cancer Immunotherapy: immune checkpoint inhibitors, cancer vaccines, and adoptive T-cell therapies

  • $ 2 495
  • Industry report
  • September 2014
  • by CHI Insight Pharma Reports

... Cancer vaccines as anti-cancer therapiesfigure 5.5: T-cell based adoptive immunotherapyfigure 5.6: Availability of car-based adoptive immunotherapies ...

Cough - Pipeline Review, H2 2014

Cough - Pipeline Review, H2 2014

  • $ 2 000
  • Company report
  • August 2014
  • by Global Markets Direct

... Reduced diphtheria toxoid + acellular pertussis vaccine adsorbed - drug profile 40product description 40mechanism of action 40r&d progress 40tak-361s - drug profile 41product description ...

Tetanus - Pipeline Review, H2 2014

Tetanus - Pipeline Review, H2 2014

  • $ 2 000
  • Company report
  • August 2014
  • by Global Markets Direct

... Diphtheria + tetanus + pertussis (acellular) + hepatitis b + poliomyelitis (inactivated) + haemophilus influenza polysaccharide conjugate [serogroup b] vaccine - drug profile 47product description 47 ...

About 10 000 reports for Vaccine

Download Unlimited Documents from Trusted Public Sources

Pathology Description in the US

  • Prevention of Measles, Rubella, Congenital Rubella Syndrome, and...
  • June 2013
    40 pages
  • Infectious Dise...  

    Measles  

    Mumps  

  • United States  

View report >

Global Vaccine Supply

November 2012

27 Companies for Vaccine

Read our Company Profiles

GlaxoSmithKline P.L.C.

United States

Novartis Inc.

Switzerland

GlaxoSmithKline PLC

United Kingdom

Johnson and Johnson

United States

Abbott Laboratories

United States

ReportLinker is an award-winning market research solution that finds, filters and organizes the latest industry data so you get all the market research you need - quickly, in one place.